Scarica l'app Stockscreener
4.11
34.31%
1.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cytosorbents Corp Borsa (CTSO) Ultime notizie
Cytosorbents Corporation (CTSO) Stock Price, News, Quote & History - Yahoo! Finance Canada
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care - prnewswire.com
Cytosorbents Corporation (CTSO) stock price, news, quote and history - uk.finance.yahoo.com
Cytosorbents Corporation (CTSO) stock price, news, quote and history - Yahoo Finance Singapore
CytoSorbents regains Nasdaq $1.00 minimum bid compliance; MVLS shortfall remains under review - TradingView
Nasdaq keeps CytoSorbents (NASDAQ: CTSO) on watch after $1 bid price return - Stock Titan
CytoSorbents regains Nasdaq minimum bid price compliance - Investing.com
CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire
CytoSorbents Regains Compliance With Nasdaq Minimum Bid Price Requirement - Moomoo
Cytosorbents Corp (CTSO) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
Cytosorbents Corp (CTSO) Q1 2023 Earnings ReportResults, Call & Slides - TipRanks
Cytosorbents Corp (CTSO) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Cytosorbents Corp (HQE) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
Cytosorbents Corp (HQE) Q1 2023 Earnings ReportResults, Call & Slides - TipRanks
CEO Phillip Chan Buys 3,774 Shares of CytoSorbents Corp (CTSO) - GuruFocus
Cytosorbents CEO Phillip Chan buys $22,644 in common stock - Investing.com
Cytosorbents (CTSO) CEO adds to stake in open-market buy - Stock Titan
Cytosorbents president & COO Vincent Capponi buys $12,536 in stock By Investing.com - Investing.com India
Cytosorbents president & COO Vincent Capponi buys $12,536 in stock - Investing.com
Cytosorbents (CTSO) director buys shares in open-market trades without a preset plan - Stock Titan
Cytosorbents (CTSO) COO adds shares in open‑market buy - Stock Titan
CytoSorbents at H.C. Wainwright conference: breakeven, drug hopes - Investing.com
CytoSorbents Corp (STU:HQE) Stock Price & 30 Year Financial Data - GuruFocus
CytoSorbents to present at H.C. Wainwright conf... - Pluang
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Morningstar
Cytosorbents CEO Phillip Chan buys 200,000 shares for $70,000 - Investing.com India
Cytosorbents CEO Phillip Chan buys 200,000 shares for $70,000 By Investing.com - Investing.com South Africa
Cytosorbents CEO Phillip Chan buys 200,000 shares for $70,000 By Investing.com - Investing.com Nigeria
Cytosorbents CEO Phillip Chan buys 200,000 shares for $70,000 - Investing.com
Cytosorbents CEO Phillip Chan buys 200,000 shares for $70,000 By Investing.com - Investing.com Canada
Cytosorbents Corp (CTSO) CEO bought more shares in the open market, adding to his stake - Stock Titan
CytoSorbents Corp (STU:HQE) Stock Earnings Transcripts - GuruFocus
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights - easternprogress.com
CytoSorbents to present at Moody Capital Soluti... - Pluang
CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference - The Globe and Mail
CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference - TradingView
CytoSorbents Plans 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing - citybiz
CytoSorbents to implement 1-for-20 reverse stoc... - Pluang
CytoSorbents Announces Reverse Stock Split - Morningstar
CytoSorbents Announces Reverse Stock Split - Yahoo Finance
CytoSorbents Announces Reverse Stock Split - PR Newswire
CTSO Looks 61.4% Undervalued on GF Value™ Amid Challenging Funda - GuruFocus
CytoSorb reduces severe bleeding by 37% in urge... - pluang.com
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings - Yahoo Finance
A blood-cleansing device was linked to 37% less severe bleeding in urgent heart surgery - Stock Titan
Cytosorbents Earnings Call Balances Progress and Risk - The Globe and Mail
Cytosorbents Earnings Call Balances Progress and Risk - TipRanks
Cytosorbents (CTSO) Financial Update: EPS Comes in Below Forecast; Market Follow-Through: Shares Finish 4.56% LowerEarnings Season Outlook - vinanet.vn
CTSO: CytoSorbents Future Value Drivers Support Price Target of $4.00 - Yahoo Finance
1.69%
3.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):